These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 28871458)

  • 1. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
    Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
    Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
    J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.
    Yang Y; Qin Z; Du D; Wu Y; Qiu S; Mu F; Xu K; Chen J
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):48-59. PubMed ID: 30151798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of irreversible electroporation combined with chemotherapy in stage IV pancreatic cancer treatment.
    Zeng J; Liu B; Lang X; Wang Z; Fan Y; Gao C; Fu D
    J Cancer Res Ther; 2024 Aug; 20(4):1357-1361. PubMed ID: 39206999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Oct; 8(47):81967-81977. PubMed ID: 29137237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
    He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
    BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
    Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
    Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients.
    Lin M; Zhang X; Liang S; Luo H; Alnaggar M; Liu A; Yin Z; Chen J; Niu L; Jiang Y
    Signal Transduct Target Ther; 2020 Oct; 5(1):215. PubMed ID: 33093457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
    Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
    Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
    Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.